These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34043813)

  • 1. Decision fatigue in low-value prostate cancer screening.
    Hunt TC; Ambrose JP; Haaland B; Kawamoto K; Dechet CB; Lowrance WT; Hanson HA; O'Neil BB
    Cancer; 2021 Sep; 127(18):3343-3353. PubMed ID: 34043813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared decision making in prostate-specific antigen testing: the effect of a mailed patient flyer prior to an annual exam.
    Landrey AR; Matlock DD; Andrews L; Bronsert M; Denberg T
    J Prim Care Community Health; 2013 Jan; 4(1):67-74. PubMed ID: 23799692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
    Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
    Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
    Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
    J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening.
    Elstad EA; Sutkowi-Hemstreet A; Sheridan SL; Vu M; Harris R; Reyna VF; Rini C; Earp JA; Brewer NT
    Med Decis Making; 2015 May; 35(4):467-76. PubMed ID: 25637592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Shared decision-making" for prostate cancer screening: Is it a marker of quality preventative healthcare?
    Golijanin B; Bhatt V; Homer A; Malshy K; Ochsner A; Wales R; Khaleel S; Mega A; Pareek G; Hyams E
    Cancer Epidemiol; 2024 Feb; 88():102492. PubMed ID: 38056246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with appropriate and low-value PSA testing.
    Oswald N; Lin T; Haaland B; Flynn M; Kawamoto K; Cooney KA; Lowrance W; Hanson HA; O'Neil B
    Cancer Epidemiol; 2020 Jun; 66():101724. PubMed ID: 32361642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinician interest in clinical decision support for PSA-based prostate cancer screening.
    Harper J; Hunt T; Choudry M; Kapron AL; Cooney KA; Martin C; Ambrose J; O'Neil B
    Urol Oncol; 2023 Mar; 41(3):145.e17-145.e23. PubMed ID: 36610816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National evidence on the use of shared decision making in prostate-specific antigen screening.
    Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
    Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patient recall program to enhance decisions about prostate cancer screening: a feasibility study.
    Denberg TD; Bhide M; Soenksen A; Mizrahi T; Shields L; Lin CT
    BMC Fam Pract; 2009 Nov; 10():75. PubMed ID: 19948028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
    Zanwar P; Lin YL; Kuo YF; Goodwin JS
    BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?
    Amin HS; Arafa MA; Farhat KH; Rabah DM; Altaweel AA; Alhammad AH
    Afr Health Sci; 2020 Dec; 20(4):1870-1874. PubMed ID: 34394251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.
    Fedewa SA; Gansler T; Smith R; Sauer AG; Wender R; Brawley OW; Jemal A
    Ann Fam Med; 2018 Mar; 16(2):139-144. PubMed ID: 29531105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending.
    Kim DD; Daly AT; Koethe BC; Fendrick AM; Ollendorf DA; Wong JB; Neumann PJ
    JAMA Netw Open; 2022 Nov; 5(11):e2243449. PubMed ID: 36413364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test.
    McCormick ME; Haile ZT
    J Cancer Educ; 2023 Aug; 38(4):1313-1321. PubMed ID: 36652189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.